Skye Bioscience, Inc. (SKYE)
0.76
-0.02
(-2.23%)
USD |
NASDAQ |
Feb 10, 10:15
Skye Bioscience Accounts Payable (Quarterly) : 2.825M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 14.66M |
| Eli Lilly & Co. | -- |
| Theravance Biopharma, Inc. | 2.213M |
| Viking Therapeutics, Inc. | 4.413M |
| Kyntra Bio, Inc. | 5.093M |